Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Coastlands Capital LP, holds the title of 10% Owner at Pasithea Therapeutics Corp..
On 2026-11-17, the insider transacted 1,667,514 shares.The shares were transacted at a weighted average price of $0.48 per share, resulting in a total market-relevant value of $806K.
Coastlands Capital LP (10% Owner) bought $806K of $KTTA
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.